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Abstract
Bordetella adenylate cyclase toxin (CyaA) binds the aMb2 integrin (CD11b/CD18, Mac-1, or CR3) of myeloid phagocytes and
delivers into their cytosol an adenylate cyclase (AC) enzyme that converts ATP into the key signaling molecule cAMP. We
show that penetration of the AC domain across cell membrane proceeds in two steps. It starts by membrane insertion of a
toxin ‘translocation intermediate’, which can be ‘locked’ in the membrane by the 3D1 antibody blocking AC domain
translocation. Insertion of the ‘intermediate’ permeabilizes cells for influx of extracellular calcium ions and thus activates
calpain-mediated cleavage of the talin tether. Recruitment of the integrin-CyaA complex into lipid rafts follows and the
cholesterol-rich lipid environment promotes translocation of the AC domain across cell membrane. AC translocation into
cells was inhibited upon raft disruption by cholesterol depletion, or when CyaA mobilization into rafts was blocked by
inhibition of talin processing. Furthermore, CyaA mutants unable to mobilize calcium into cells failed to relocate into lipid
rafts, and failed to translocate the AC domain across cell membrane, unless rescued by Ca
2+ influx promoted in trans by
ionomycin or another CyaA protein. Hence, by mobilizing calcium ions into phagocytes, the ‘translocation intermediate’
promotes toxin piggybacking on integrin into lipid rafts and enables AC enzyme delivery into host cytosol.
Citation: Bumba L, Masin J, Fiser R, Sebo P (2010) Bordetella Adenylate Cyclase Toxin Mobilizes Its b2 Integrin Receptor into Lipid Rafts to Accomplish
Translocation across Target Cell Membrane in Two Steps. PLoS Pathog 6(5): e1000901. doi:10.1371/journal.ppat.1000901
Editor: Kenneth A. Bradley, University of California Los Angeles, United States of America
Received September 29, 2009; Accepted April 7, 2010; Published May 13, 2010
Copyright:  2010 Bumba et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants GA310/07/P115 (LB), 1M0506 (JM), IAA500200914, 2B06161 and GA310/08/0447 (PS), and the Institutional Research
Concepts AV0Z50200510, AV0Z50520701 and MSM0021620858 (RF). http://www.gacr.cz/international.htm; http://www.gaav.cz/en/; http://www.msmt.cz/index.
php?lchan=1&lred=1; http://www.biomed.cas.cz/mbu/en/. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sebo@biomed.cas.cz
Introduction
The secreted adenylate cyclase toxin-hemolysin (CyaA, ACT, or
AC-Hly) plays a key role in virulence of Bordetellae. This multi-
fuctional protein binds the aMb2 integrin (CD11b/CD18, CR3 or
Mac-1) of myeloid phagocytic cells and delivers into their cytosol a
calmodulin-activated adenylate cyclase enzyme that ablates bacte-
ricidal capacities of phagocytes by uncontrolled conversion of
cytosolic ATP to the key signaling molecule cAMP [1–5]. In
parallel, the hemolysin moiety of CyaA forms oligomeric pores that
permeabilize cell membrane for monovalent cations and contribute
to overall cytoxicity of CyaA towards phagocytes [6–10].
The toxin is a 1706 residues-long protein, in which a
calmodulin-activated adenylate cyclase (AC) enzyme domain of
,400 N-terminal residues is fused to a ,1300 residue-long RTX
(Repeats in ToXin) cytolysin moiety [11]. The latter consists itself
of three functional domains typical for RTX hemolysins. It
harbors, respectively, (i) a hydrophobic pore-forming domain, (ii) a
segment recognized by the protein acyltransferase CyaC, activat-
ing proCyaA by covalent post-translational palmitoylation at e-
amino groups of Lys860 and Lys983 [12,13], and (iii) an assembly of
five blocks of the characteristic glycine and aspartate-rich
nonapeptide RTX repeats that form numerous (,40) calcium-
binding sites [14].
Since no structural information on the RTX cytolysin moiety is
available, the mechanistic details of toxin translocation across the
lipid bilayer of cell membrane remain poorly understood. Delivery
of the AC domain into cells occurs directly across the cytoplasmic
membrane, without the need for toxin endocytosis [15] and
requires structural integrity of the CyaA molecule [6], unfolding of
the AC domain [16] and a negative membrane potential [17].
Recently, we described that CyaA forms a calcium-conductive
path in cell membrane and mediates influx of extracellular Ca
2+
ions into cell cytosol concomitantly with translocation of the AC
domain polypeptide into cells [18].
The current working model predicts that both Ca
2+ influx and
AC translocation depend on a different membrane-inserted CyaA
conformer than the pore-forming activity [19,20]. The two
membrane activities of CyaA, however, appear to use the same
essential amphipatic transmembrane segments within the pore-
forming domain (a-helix502–522 and a-helix565–591), employing
them in an alternative and mutually exclusive way. These
segments harbor two pairs of negatively charged glutamate
residues (Glu509/Glu516 and Glu570/Glu581) that were found to
play a central role in toxin action on cell membrane. These
control, respectively, the translocation of the positively charged
AC domain, the formation of oligomeric CyaA pores and the
cation-selectivity of the CyaA pore. Charge-reversing, neutral or
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the balance between AC translocating and pore-forming activities
of CyaA on cell membrane [8,10,19,20].
The very high specific AC enzyme activity of CyaA allowed
previously to detect its capacity to promiscuously bind and
penetrate at reduced levels also numerous cell types lacking the
CD11b/CD18 receptor [21,22]. This is likely due to a weak
lectin activity of CyaA, which would enable interaction of the
toxin with cell surface gangliosides [23] and glycoproteins [24].
Indeed, binding of CyaA to CD11b/CD18 was recently found
to depend on initial interaction with the N-linked glycan
antenna of the receptor [24], where the specificity of CyaA for
CD11b/CD18 appears to be determined by a segment of the
stalk domain of the CD11b subunit (Osicka et al., manuscript in
preparation).
CD11b/CD18 belongs to the b2 subfamily of polyfunctional
integrins playing a major role in leukocyte function. The same b2
subunit (CD18) can, indeed, pair with four distinct a subunits to
yield the aLb2 (CD11a/CD18, LFA-1), aMb2 (CD11b/CD18,
CR3, Mac1), aXb2 (CD11c/CD18, p150/195) and aDb2
(CD11d/CD18) receptors, respectively [25]. Among key features
of these integrins is their capacity of bi-directional signaling, where
the avidity and conformation of the integrins is regulated by
intracellular signals in the ‘inside-out’ signaling mode. In turn,
binding of ligands or counter-receptors results in ‘outside-in’
signaling [26]. Among other effects, the latter yields actin
cytoskeletal rearrangements and can result in lateral segregation
of the b2 integrins from the bulk phase of the plasma membrane
into distinct lipid assemblies known as lipid rafts [27,28]. These
were first detected as detergent-resistant membrane (DRM),
characterized by insolubility in some detergents under certain
conditions and enriched in cholesterol, sphingolipids, and
glycosylphosphatidylinositol-anchored proteins [29–32]. Besides
playing an important role in signal transduction, receptor
internalization, vesicular sorting or cholesterol transport [33],
the components of lipid rafts are often exploited as specific
receptors mediating cell entry of toxins, pathogenic bacteria, or
viruses [34–36].
Here, we show that CyaA-mediated influx of Ca
2+ ions into cells
induces mobilization of the toxin-receptor complex into lipid rafts,
where translocation of the AC domain across cytoplasmic
membrane is accomplished.
Results
CyaA entrains its CD11b/CD18 receptor into lipid rafts
To examine whether CyaA localizes to lipid rafts, murine
J774A.1 monocytes exposed to 1 nM CyaA (176 ng/ml, 37uC,
10 min) were lyzed with ice-cold Triton X-100 and detergent-
resistant membrane (DRM) was separated from soluble cell
extracts by flotation through sucrose density gradients. As shown
in Fig. 1A, while the CD71 marker of bulk membrane phase was
exclusively detected in the soluble extract at the bottom of the
gradient, up to 30% of total loaded CyaA was found to float in
fraction 3 at a lower buoyant density towards the top of the
gradient, together with the DRM marker protein NTAL (see
Fig. 1E for quantification).
Notably, while over 50% of the full-length CyaA molecules
(,200 kDa) remained in the soluble phase at the bottom of the
gradient, the floating DRM fractions were selectively enriched in a
processed CyaA form of ,160 kDa, representing up to 60% of
total CyaA in the fraction 3 of the gradient (see Fig. 1F for
quantification). This appeared to have the entire AC domain-
cleaved off, as it could only be detected by the 9D4 antibody
recognizing the C-terminal RTX repeats and not by the 3D1
antibody binding between residues 373 and 399 of the C-terminal
end of the AC domain of CyaA [37]. Most CyaA molecules
accumulating in DRM appeared, hence, to have the AC domain
translocated across cellular membrane and accessible to processing
by intracellular proteases [10,38].
As further documented in Fig. 1B, no CD11b was floating with
DRM from mock-treated J774A.1 cells, or when toxin binding
occurred at 4uC. In turn, exposure of monocytes to 1 nM CyaA at
37uC, resulted in mobilization of over 30% of total cellular CD11b
into the floating DRM, showing that CyaA relocated from the
bulk of the membrane to DRM together with its aMb2 integrin
receptor. This was, however, not due to any generalized clustering
and mobilization of b2 integrins into rafts resulting from toxin
action, as the highly homologous CD11a subunit of the other b2
integrin expressed by J774A.1 cells (LFA-1), was not mobilized
into DRM (Fig. 1B). Hence, the relocation of CD11b/CD18 into
rafts was specifically due to interaction with CyaA.
To assess whether CyaA association with DRM depended on
toxin interaction with CD11b/CD18, we used Chinese hamster
ovary (CHO) cells that do not express any b2 integrins unless
transfected by genes encoding CD11b and CD18 subunits (CHO-
CD11b/CD18). As shown in Fig. 1C, even when the CyaA
concentration was raised to 113 nM, to obtain detectable amounts
of the toxin associated with mock-transfected CHO cells, CyaA
was detected exclusively in the soluble extract at the bottom of the
gradient. In contrast, association of CyaA and CD11b/CD18 with
DRM was detected already upon treatment of CHO-CD11b/
CD18 transfectants with 1 nM CyaA (Fig. 1D). This showed that
CyaA depended on binding to CD11b/CD18 for association with
DRM and it was able to mobilize CD11b/CD18 into DRM
independently of the myeloid cell background.
Mobilization of the CyaA-CD11b/CD18 complex into lipid
rafts depends on AC domain translocation and influx of
extracellular calcium ions
Since CyaA exerts several activities on cells in parallel, we
analyzed which of them enabled mobilization of the CyaA-
CD11b/CD18 complex into DRM. Towards this aim, we used a
specific set of CyaA variants that retain the capacity to bind
Author Summary
The adenylate cyclase toxin (CyaA) of pathogenic Borde-
tellae eliminates the first line of host innate immune
defense. It penetrates myeloid phagocytes, such as
neutrophils, macrophage or dendritic cells, and subverts
their signaling by catalyzing an extremely rapid conversion
of intracellular ATP to the key signaling molecule cAMP.
This efficiently inhibits the oxidative burst and comple-
ment-mediated opsonophagocytic killing of bacteria, thus
enabling the pathogen to colonize host airways. We show
that translocation of CyaA into phagocyte cytosol occurs in
two steps. The toxin first binds the integrin CD11b/CD18
and inserts into phagocyte membrane to mediate influx of
calcium ions into cells. This promotes relocation of the
toxin-receptor complex into specific lipid microdomains
within cell membrane called rafts. The increased concen-
trations of cholesterol within rafts and their particular lipid
organization then support translocation of the adenylate
cyclase enzyme directly into the cytoplasmic compartment
of cells. The mechanism of CyaA penetration into cells sets
a new paradigm for membrane translocation of toxins of
the RTX family.
CyaA Translocation across Cell Membrane
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activities (Table 1). As documented in Fig. 2A, the capacity of
CyaA to elevate cellular cAMP concentrations was not required
for mobilization of CyaA into DRM. The enzymatically-inactive
CyaA-AC
2 construct, unable to catalyze conversion of ATP into
cAMP, was indeed accumulating in DRM with the same efficacy
as the intact CyaA (fractions 3–4). Fatty-acylation of CyaA as such
was also not essential for association of CyaA with DRM. As
further shown in Fig. 2A, the non-acylated proCyaA was detected
in DRM despite an importantly reduced capacity to associate with
cells. Moreover, the pore-forming activity of CyaA was both
insufficient and dispensable for mobilization of CyaA into DRM.
The acylated CyaADAC construct, lacking the entire AC domain
but retaining an intact pore-forming (hemolytic) capacity, was
unable to mobilize into DRM (Fig. 2A). In contrast, the CyaA-
E570Q+K860R-AC
2 construct unable to permeabilize cells to
any significant extent, but exhibiting an intact capacity to
translocate the AC domain across cell membrane was, indeed,
recruited into DRM together with CD11b/CD18 as efficiently as
intact CyaA. In turn, the CyaA-E570K+E581P double mutant
that was unable to form CyaA pores, or to translocate the AC
domain across membrane, and retained only the CD11b-binding
capacity (Table 1), was also unable to associate with DRM.
To corroborate these observations, we used fluorescence
microscopy to examine the distribution of individual CyaA
proteins in cell membrane. As documented in Fig. 2B, the intact
CyaA, CyaA-AC
2 and CyaA-E570Q+K860R-AC
2 proteins were
found to induce formation of, and to localize within, patches on
cell membrane. Moreover, the same patches were labeled to high
extent also with B subunit of cholera toxin (CtxB), which
specifically binds the GM1 ganglioside accumulating in lipid rafts.
Hence, the three CyaA variants capable of associating with DRM
(cf. Fig. 2A) were also found to co-localize with CtxB within
membrane patches. In turn, no formation of membrane patches, a
diffuse distribution on cell surface, and low if any co-localization
with CtxB, were observed for the CyaADAC and CyaA-
E570K+E581P constructs that were unable to associate with
DRM, too.
Figure 1. CyaA entrains CD11b/CD18 into lipid rafts. J774A.1 cells were mock-treated with buffer, or incubated with 1 nM CyaA at 37uC for
10 min (CyaA-treated). Cells were placed on ice and extracted at 4uC for 60 minutes in buffer containing 1% Triton X-100. Cell lyzates were
fractionated by flotation in buoyant sucrose density gradients at 150,0006g in a Beckman SW60Ti rotor at 4uC for 16 h. Gradient fractions were
analyzed by Western blotting. (A) Unless otherwise stated, CyaA was detected using the 9D4 monoclonal antibody (MAb) recognizing the C-terminal
RTX repeats. The 3D1 MAb was used to specifically detect the distal part (aa 373–400) of the AC domain of CyaA [37]. The full-length CyaA
(,200 kDa) and the processed form of CyaA (,160 kDa) are indicated by a crossline (6) and a square symbol (%), respectively. (B) CD11b was
detected with the OKM-1 antibody on native immunoblots of Blue-native PAGE gels, while conventional Western blots were used for detection of
CyaA and CD11a by 9D4 and MEM-25 antibodies, respectively. (C) Chinese hamster ovary (CHO) cells were mock-treated or incubated with 113 nM
CyaA at 37uC for 10 min. (D) CHO cells stably transfected with genes encoding the human CD11b/CD18 integrin subunits (CHO-CD11b/CD18) were
incubated with 1 nM CyaA at 37uC for 10 min. CyaA and CD18 were detected with 9D4 and MEM-48, respectively. Lanes 1–8 correspond to gradient
fractions. Representative immunoblots from at least 3 independent experiments are shown. (E) Distribution of CyaA (filled bars) and CD11b (open
bars) across sucrose density gradient. The values for relative amounts of CyaA and CD11b, detected in a given fraction of the gradient and expressed
as % of total detected protein, were derived from densitometric analysis of immunoblots. (F) Relative abundance of the processed form of CyaA
(160 kDa) was expressed as % of total CyaA detected within a given fraction of the gradient. Values represent the mean 6 S.D. of three independent
experiments. N.D., not determined.
doi:10.1371/journal.ppat.1000901.g001
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form and co-localization of the different CyaA variants with CtxB,
respectively, resembled strongly the pattern of structure-function
relationships observed recently for the capacity of CyaA to
promote influx of extracellular calcium ions into J774A.1 cells
[18]. Indeed, as documented in Fig. 2C by measurements of
intracellular calcium concentrations ([Ca
2+]i), the CyaA, CyaA-
AC
2 and CyaA-E570Q+K860R-AC
2proteins (17 nM) exhibited
an expected capacity to promote Ca
2+ influx into J774A.1 cells (see
[18] for details on different kinetics of Ca
2+ entry for AC
2 and
AC
+ constructs). In contrast, the CyaA-E570K+E581P and
CyaADAC constructs, failed to mediate any increase of [Ca
2+]i
even when used at a 113 nM concentration (Fig. 2D). Collectively,
hence, these results show that the capacity of different CyaA
variants to associate with DRM and co-localize with CtxB within
coalesced lipid rafts was mirrored by the capacity to promote Ca
2+
influx into cells.
Membrane insertion of a ‘translocation intermediate’
allows calcium influx and CyaA association with DRM
We showed recently that CyaA-mediated influx of Ca
2+ into cells
is independent of the AC enzyme or pore-forming (hemolytic)
activities of CyaA and occurs concomitantly to translocation of the
AC domain across target cell membrane [18]. It remained,
however, to assess whether it was the mere insertion of a CyaA
translocation precursor into cell membrane, or whether the
accomplishment of translocation of the AC domain across cell
membrane was required for formation of a calcium conductive path
in cell membrane. Towards this aim, we used the 3D1 monoclonal
antibody (MAb) that binds to the distal end of the AC domain
(residues 373 to 400) and was previously shown to block membrane
translocation of the AC domain of cell-associated CyaA [39]. As
expected and documented in Fig. 3A, preincubation of CyaA with
the 3D1 MAb did not affect the capacity of CyaA to bind J774A.1
cells, while strongly inhibiting AC domain delivery and cAMP
concentration elevation in cells. However, as revealed by detection
of both CyaA and 3D1 in the fraction 3 of the sucrose gradient
shown in Fig. 3B, the membrane-inserted CyaA with bound 3D1
MAb still associated with DRM at the same levels as CyaA alone.
Moreover, as also shown in Fig. 3B,due to 3D1-mediatedinhibition
of AC domaintranslocation, the relative amount of processed CyaA
(,160 kDa) in the DRM fractions decreased to 10 to 15% of total
present CyaA, while over 50% of CyaA in DRM was processed in
the presence of isotype control.
As shown in Fig. 3C, however, despite arrested AC domain
translocation, the CyaA-3D1 complex promoted elevation of
[Ca
2+]i in cells with kinetics resembling the Ca
2+ influx produced
by CyaA-AC
2 (cf. Fig. 2C). Hence, 3D1 binding uncoupled
translocation of the AC domain from membrane insertion of
CyaA and ‘locked’ the toxin in the conformation of a
‘translocation intermediate’ that permeabilized cells for Ca
2+ ions
and associated with DRM.
Influx of Ca
2+ induces association of CyaA with DRM
Next, we aimed to determine whether elevation of [Ca
2+]i as
such would mobilize into DRM also the CyaA-E570K+E581P
protein unable to associate with DRM on its own (cf. Fig. 2). As
demonstrated in Fig. 4, upon permeabilization of cells for
extracellular Ca
2+ ions with the Ca
2+ ionophore ionomycin
(500 nM), up to 15% of the added CyaA-E570K+E581P was
found associated with DRM. In contrast, no association of CyaA-
E570K+E581P with DRM was observed upon treatment of cells
with 1 mM thapsigargin that increases [Ca
2+]i by triggering Ca
2+
release from intracellular stores. This showed that entry of
extracellular Ca
2+ across the cytoplasmic membrane was required
for mobilization of CyaA into DRM.
Recruitment of CyaA-CD11b/CD18 complexes into rafts
depends on cleavage of cytosolic talin by the
Ca
2+-activated protease calpain
Influx of extracellular Ca
2+ during leukocyte activation was
reported to induce mobilization of integrins in cell membrane by
calpain-mediated cleavage of talin that tethers b2 integrins to actin
cytoskeleton [40,41]. Therefore, we examined whether CyaA-
promoted recruitment of the toxin receptor into rafts depended on
talin processing. As shown in Fig. 5A, intact talin (,270 kDa) was
largely predominating in lyzates of cells treated with the CyaA-
DAC or CyaA-E570K-E581P proteins that are unable to promote
Ca
2+ entry into cells. In contrast exposure of cells to the CyaA,
CyaA-AC
2, or CyaA-E570Q+K860R-AC
2 proteins, promoting
Table 1. Relative toxin activities of CyaA-derived constructs.
Protein AC enzyme activity
a
CD11b
+ cell
binding [%]
b
Hemolytic
activity [%]
c
AC domain
translocation [%]
d
Calcium
influx
e
CyaA + 100 100 100 +++
CyaA-AC
2 2 N.D. (100
f)9 6 612 N.D. (100
g) +++
proCyaA + 2368 ,13 61 +
CyaA-E570K+E581P + 91615 ,11 . 8 60.5 2
CyaA-DAC 2 N.D. (100
f)1 0 9 615 22
CyaA-E570Q+K860R-AC
2 2 N.D. (100
f) ,1 N.D. (100
g) +++
aCapacity to catalyze conversion of ATP to cAMP.
bAC enzyme activity associated with J774A.1 cells (10
6/ml) upon incubation with 6 nM protein for 30 min at 4uC. Relative activity of intact CyaA was taken as 100%.
cDetermined as the amount of hemoglobin (A541 nm) released from washed sheep erythrocytes (5.10
8/ml) by 5 mg/ml of protein at 37uC.
dAmounts of intracellular cAMP per 10
5 J774A.1 cells incubated with indicated proteins for 30 min at 37uC.
eThe number of plus signs reflects the relative ability of CyaA proteins to increase [Ca
2+]i levels (c.f. Fig. 2).
fDue to lack of AC enzyme activity, the capacity of these proteins to bind the J774A.1 cells could not be quantified directly. The capacity of these constructs to compete
for the CD11b/C18 receptor with CyaA-biotin, however, is indistinguishable from that of intact CyaA (100% activity, data not shown).
gThe capacity to translocate the AC domain polypeptide could not be quantified for these constructs because of lack of AC enzyme activity. It can, however, be deduced
from the capacity of corresponding constructs to deliver an inserted OVA epitope (SIINFEKL) into the cytosol of antigen-presenting cells for processing and subsequent
presentation to specific CD8
+ T cells in complex with major histocompatibility complex I molecules [63].
doi:10.1371/journal.ppat.1000901.t001
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2+ influx. (A) J774A.1 cells were incubated with 1 nM CyaA-
derived proteins at 37uC for 10 min, cell lyzates were fractionated on sucrose gradients and proteins were detected by immunoblots as described for
Fig. 1. (B) J774A.1 cells were incubated at 37uC for 10 min with 6 nM CyaA proteins labeled with Alexa Fluor 488 before 5 mg/ml of Alexa Fluor 594-
labeled recombinant cholera toxin subunit B (CtxB) was added for additional 5 min. The cell-bound proteins were visualized by fluorescence
microscopy and co-localization of CyaA (green) with CtxB (red) was assessed in the merged images (yellow). Representative images from two
independent experiments are shown. Note that intact CyaA induced the reported cAMP-dependent ruffling of J774A.1 cells [2]. (C and D) CyaA
induces increase of cytosolic calcium concentration ([Ca
2+]i). J774A.1 cells were loaded with the Ca
2+ probe Fura-2/AM (3 mM) at 25uC for 30 min and
exposed to 17 nM (C) or 113 nM (D) CyaA proteins. Time course of Ca
2+ entry was recorded as the ratio of fluorescence intensities (excitation at 340/
380 nm, emmision 505 nm), as previously described [18]. The shown curves are representative of at least three independent experiments.
doi:10.1371/journal.ppat.1000901.g002
CyaA Translocation across Cell Membrane
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2+ into cells, increased about seven-fold the detected
amounts of the ,220 kDa C-terminal fragment of processed talin
(Fig. 5A, left panel). Concomitantly, increased amounts of the 47-
kDa N-terminal fragment of talin (talin head) were detected in cell
lyzates. Moreover, tightly associated talin head was found to float
together with the CD11b/CD18 heterodimer in DRM (Fig. 5B)
and could be co-immunoprecipitated with the integrin on beads
coated with anti-CD11b antibody (Fig. 5C). This CyaA-induced
processing of talin was clearly due to activation of calpain, as
preincubation of cells with 100 mM calpain inhibitor, calpeptin,
blocked talin cleavage in CyaA-treated cells (Fig. 5A, right panel).
Remarkably, pretreatment of cells with calpeptin strongly
inhibited also the association of CyaA with DRM (Fig. 5D) and
decreased by at least a factor of two the capacity of cell-associated
CyaA to translocate the AC enzyme into target cells (Fig. 5E). In
turn, no effect of calpain inhibition was observed for CyaA-
mediated Ca
2+ influx (Fig. 5F). In line with these results,
pretreatment of cells with 100 mM calpeptin blocked effectively
also the formation of CyaA-AC
2 patches in cell membrane and
ablated co-localization of CyaA-AC
2 with CtxB, as documented
in Fig. 5G. It can, hence, be concluded that CyaA-mediated influx
of Ca
2+ into cells activated cleavage of talin by calpain and this was
required for mobilization of CyaA-CD11b/CD18 complexes into
lipid rafts.
Figure 3. Binding of 3D1 antibody uncouples AC translocation from membrane insertion and CyaA-mediated Ca
2+ influx. (A) 17 nM
CyaA was preincubated for 20 min at 37uC with 20 mg/ml of 3D1 MAb (CyaA+3D1) or the Tu-01 IgG1 isotype control MAb (CyaA+isotype control),
before 6 nM toxin was added to J774A.1 cells. CyaA binding was determined as the amount of total cell-associated AC enzyme activity upon cells
incubation with 6 nM CyaA for 10 min at 37uC in the presence or absence of the indicated antibody. AC domain translocation was assessed by
determining the intracellular concentration of cAMP generated in cells in the presence or absence of the indicated antibodies, following incubation
of cells with four different toxin concentrations from within the linear range of the dose-response curve (0.05, 0.1, 0.25, and 0.5 nM). The % of cAMP
accumulation in cells at each toxin concentration was calculated, taking cAMP values for CyaA preincubated in buffer alone as 100%. The average of
such determined % activity values is given. An asterisk indicates a statistically significant difference (*, p,0.01; Student’s t test). (B) J774A.1 cells were
exposed to 1 nM CyaA alone, or to 1 nM CyaA preincubated with 3D1 or IgG1 isotype MAb as above. Cell lyzates were separated on sucrose density
gradients and analyzed as in Fig. 1. The 3D1 and isotype IgG1 MAbs were detected with anti-mouse IgG antibody. The relative amounts of processed
CyaA (,160 kDa) within individual gradient fractions were determined as in Fig. 1F. Values represent the mean 6 S.D. of three independent
experiments. An asterisk indicates a statistically significant difference (*, p,0.05; Student’s t test). N.D., not determined. (C) J774A.1 cells were loaded
with Fura-2/AM as above and exposed to 17 nM CyaA alone, or to CyaA preincubated with 3D1 or an IgG1 isotype control MAb. Ca
2+ influx was
recorded as above and the shown curves are representative of three independent experiments.
doi:10.1371/journal.ppat.1000901.g003
CyaA Translocation across Cell Membrane
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2+ influx, lipid raft association and AC translocating
activity of CyaA depend on cholesterol content of target
cell membrane
To determine what role does association of CyaA with lipid rafts
play in the mechanism of toxin action on cellular membrane, we
analyzed the activities of CyaA on cells having the rafts disrupted
by depletion of cholesterol. As shown in Table 2, the total
cholesterol content of J774A.1 cells could be decreased about two-
fold by cholesterol extraction with 10 mM MbCD for 30 min.
While the disruption of raft structures did not impact on
association of CyaA with cells (Fig. 6A and Fig. S1), the modest
decrease of cellular cholesterol content yielded an about five-fold
decrease of the capacity of CyaA to translocate the AC domain
across cell membrane. This defect was further mirrored by
decreased DRM association of CyaA in MbCD-extracted cells, as
shown in Fig. 6B. In parallel, the specific capacity of CyaA to
promote Ca
2+ influx into cholesterol-depleted cells was reduced
and the [Ca
2+]i increase ensuing toxin addition was delayed by
several minutes, reaching a plateau at about a half-maximal
[Ca
2+]i concentration, as compared to non-depleted cells (Fig. 6C).
In line with this, the two-fold decrease of cellular cholesterol level
moderately decreased also the co-localization of CyaA with CtxB
in lipid rafts (Fig. 6D).
Therefore, the above described experiments were replicated on
monocytic U937 histiocytic lymphoma cells (CD11b
+) that are
defective in endogenous cholesterol synthesis. These cells can be
efficiently depleted of cholesterol without losing viability, by them
growing for 48 hours in media containing cholesterol-free
(delipidated) serum. As shown in Table 2, such treatment reduced
the cholesterol content of U937 cells almost 10-times.
As shown in Fig. 6E, a pronounced, over ten-fold decrease of
specific AC translocation capacity of CyaA was observed on U937
cells grown in media with delipidated serum, as compared to
CyaA activity on cells grown with standard serum. At the same
time, however, the total amounts of cell-associated CyaA remained
equal, irrespective of cell treatment. However, by difference to
well-detectable DRM association of CyaA on cholesterol-replete
U937 cells, grown with standard serum, no association of CyaA
with DRM was observed in lyzates of cholesterol-depleted U937
cells grown in delipidated serum, respectively (Fig. 6F).
Intriguingly, compared to the Ca
2+ influx elicited by equal
concentrations of CyaA in J774A.1 cells, about an order of
magnitude lower amplitude and delayed kinetics of CyaA-
mediated Ca
2+ influx was observed for U937 cells grown in media
with standard serum (cf. Fig. 6C and Fig. 6G). These cells
exhibited a 3-fold lower cholesterol content than the J774A.1 cells
(see Table 2), suggesting that the low cholesterol content of U937
cells might have accounted for the poor capacity of CyaA to elicit
Ca
2+ influx in these cells. Indeed, when cholesterol content of
J774A.1 cells was reduced about two-fold by cholesterol extraction
with 10 mM MbCD, a delayed kinetics of CyaA-induced influx of
Ca
2+ into J774A.1 cells and a two-fold lower final [Ca
2+]i reached
in 20 minutes, were also observed (cf. Fig. 6C). Similarly, a
delayed influx of Ca
2+ and a lower final level of [Ca
2+]i was
observed also upon addition of equal CyaA concentrations to
U937 cells depleted of cholesterol by growth in delipidated media,
as compared to U937 cells grown in standard media, as shown in
Fig. 6G. At the same time, however, the respective amounts of
CyaA associated per 10
6 J774A.1 or U937 cells remained the same
(,5 ng of CyaA bound per 10
6 cells), irrespective of whether the
cholesterol content of cells was decreased by the treatments (cf.
Fig. 6A and 6E). These results, hence, strongly point towards a
close relation between the overall content of cholesterol in cellular
membrane and the propensity of the membrane-inserted CyaA to
adopt the ‘translocation intermediate’ conformation, which would
account for the Ca
2+ conducting path across cell membrane (cf.
Fig. 3 and [18]).
Finally, a correspondingly reduced CtxB binding and little if any
co-localization of CtxB with CyaA were observed on cholesterol-
depleted U937 cells, grown in delipidated serum, as compared to
binding and some observable co-localization of CyaA with CtxB
on cholesterol-replete U937 cells (Fig. 6).
Mobilization of CyaA into lipid rafts enables translocation
of AC domain across membrane
In the light of the above results, we aimed to test the hypothesis
that AC translocation across membrane was supported and
accomplished upon recruitment of the membrane-associated toxin
into the cholesterol-rich environment of lipid rafts. Therefore, we
examined whether the inactive CyaA-E570K+E581P construct
would gain any capacity to translocate its enzymatically active AC
domain across cellular membrane upon mobilization into lipid
rafts. Since this mutant is intact for receptor binding but fails to
promote Ca
2+ influx into cells, we reasoned that mobilizing Ca
2+
ions into cells in trans, by co-incubation with a translocating CyaA-
AC
2 toxoid, might promote recruitment of CyaA-E570K+E581P
mutant into rafts to some extent.
As shown in Fig. 7A, when biotinylated CyaA-E570K+E581P
was added to cells alone, or when it was co-incubated with equal
Figure 4. Mobilization of CyaA into lipid rafts depends on
influx of extracellular Ca
2+ ions into cells. (A) J774A.1 cells were
incubated at 37uC for 10 min with 1 nM CyaA and CyaA-E570K+E581P,
in the presence or absence of 500 nM ionomycin , or of 1 mM
thapsigargin, respectively. Cell lyzates were analyzed on sucrose density
gradients as above. The blots are representative of four independent
experiments. (B) Distribution of CyaA proteins in gradient fractions was
quantified as in Fig. 1 and the values represent the mean 6 S.D. of three
independent experiments. An asterisk indicates a statistically significant
difference (*, p,0.05; Student’s t test).
doi:10.1371/journal.ppat.1000901.g004
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2
toxoid, unable to cause calcium influx, the CyaA-E570K+E581P-
biotin failed to associate with DRM. In contrast, upon
co-incubation with equal amounts of the translocating CyaA-
AC
2 toxoid (1:1), a significant fraction of CyaA-E570K+E581P-
biotin associated with DRM. Moreover, as shown in Fig. 7B, this
Figure 5. Mobilization of CyaA into lipid rafts depends on talin cleavage by calpain. (A) J774A.1 cells were incubated with 30 nM CyaA
proteins at 37uC for 10 min (left panel). Talin, CyaA and a-tubulin were detected in cell lyzates by Western blotting using 8d4, 9D4 and Tu-01 MAbs,
respectively. Calpain activation was inhibited by preincubation of cells with 100 mM calpeptin at 37uC for 30 min (right panel). Talin processing was
determined from Western blots as relative increase of the amount of the 220-kDa talin fragment, taking the value for untreated cells as 1. Data
represent the mean 6 S.D. from three experiments. (B) Cells were kept in buffer or pretreated with 100 mM calpeptin at 37uC for 30 min before
incubation with 1 nM CyaA at 37uC for 10 min. Talin, talin head and CyaA were detected in cell lyzates separated on sucrose density gradients using
8d4, TA-205 and 9D4 MAbs, respectively. The shown blots are representative of four independent experiments. (C) CyaA-mediated talin cleavage
promotes CD11b/CD18 release from cytoskeletal constraints. J774A.1 cells were incubated with 30 nM CyaA for 30 min at 37uC. Cell lyzates were
prepared and incubated with anti-CD11b monoclonal antibody (MEM-174) covalently coupled to CNBr-activated Sepharose beads. The beads were
washed, bound proteins were eluted with SDS-PAGE loading buffer, and talin and talin head were detected by Western blotting with 8d4 and TA-205
antibody, respectively. (D) DRM association of CyaA in J774A.1 cells kept in buffer or preincubated with 100 mM calpeptin was analyzed as above. (E)
AC translocation into control and calpeptin-pretreated J774A.1 cells were determined as described in the legend to Fig. 3. (F) CyaA-mediated influx of
Ca
2+ into untreated and calpeptin-pretreated J774A.1 cells was measured as in Fig. 2. Values represent the mean 6 S.D. of three independent
experiments. An asterisk indicates a statistically significant difference (*, p,0.05; Student’s t test). (G) J774A.1 cells grown on coverslips were kept in
buffer or pretreated with 100 mM calpeptin at 37uC for 30 min before membrane distribution of fluorescently labeled CyaA-AC
2 (6 nM, green) and
CtxB (5 mg/ml, red) was visualized as described in the legend to Fig. 2.
doi:10.1371/journal.ppat.1000901.g005
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residual capacity of the CyaA-E570K+E581P variant to deliver
the AC domain across cell membrane and elevate cytosolic cAMP
concentrations (Fig. 7B). Thus, recruitment into cholesterol-rich
lipid rafts enhanced the residual AC translocating activity of this
defective CyaA variant.
Discussion
We show here that membrane translocation of the adenylate
cyclase domain of CyaA occurs by a two step mechanism and
involves toxin piggybacking on the aMb2 integrin for relocation into
lipid rafts. The present results allow us to propose a new model of
CyaA mechanism of action, as summarized in Fig. 8. Upon initial
binding of CyaA to the CD11b/CD18 receptor distributed in the
bulk phase of cell membrane, a ‘translocation intermediate’ of CyaA
would insert into the cytoplasmic membrane. It is assumed that in this
‘translocation intermediate’ a part of the AC domain is already
inserted within the membrane and is shielded form the lipids by
association with the amphipathic a-helical transmembrane segments
of the hydrophobic domain of CyaA (residues 502–522, 529–549,
571–591, 607–627 and 678–698 [19,20]). This ‘translocation
intermediate’ then forms a path conducting external Ca
2+ ions
across cellular membrane into the submembrane compartment of
cells. Incoming calcium ions activate the Ca
2+-dependent protease
calpain, located in the submembrane compartment, which produces
cleavage of the talin tether. This liberates the toxin-receptor complex
from association with actin cytoskeleton and mobilizes it for
recruitment into lipid rafts. Within the specific liquid-ordered
environment of cholesterol-rich lipid rafts, translocation of the
positively charged AC domain across the cellular membrane is
completed, driven by the negative gradient of membrane potential.
Deciphering this fine-tuned mechanism of toxin action on cell
membrane fosters our understanding of the key role played by
CyaA in virulence of Bordetellae during the early phases of bacterial
colonization of host respiratory mucosa. It allows to propose the
following scenario. The produced CyaA targets the CD11b/CD18
receptor of incoming myeloid phagocytic cells, such as neutrophils,
macrophages and dendritic cells [42]. As CyaA action does not
depend on receptor-mediated endocytosis, the toxin recruited into
lipid rafts can rapidly translocate its highly active AC enzyme
domain across the cytoplasmic membrane of cells, in a process
exhibiting a half-time of only about ,30 seconds [38]. Mobiliza-
tion of toxin-receptor complexes into lipid rafts than promotes
their clustering and potentially induces recruitment of cellular
cAMP-responding elements, such as the protein kinase A
anchored to AKAPs, the specific A-kinase anchoring scaffolds
[43–45]. This would allow maximization of toxin action through
subversive cAMP production in close vicinity of components of the
cAMP-regulated PKA signaling pathway. This capacity to hijack
the spatio-temporal regulation of cellular cAMP/PKA signaling
would then endow CyaA with the high potency in paralyzing the
central bactericidal mechanisms employed by myeloid phagocytic
cells. Indeed, few picomoles of CyaA (1 ng/ml or less) were
previously reported to instantaneously suppress the oxidative burst
capacity of neutrophils [46], or the phagocytosis of complement-
opsonized particles by macrophages [2].
Several other bacterial protein toxins appear, indeed, to utilize
lipid rafts as a portal of cell entry, exploiting as specific receptors
directly certain raft components, such as cholesterol, sphingolipids
or GPI-anchored proteins [47–50]. In contrast, we found here that
CyaA associates with rafts only upon binding and mobilization
(hijacking) of its receptor CD11b/CD18. Unless activated in the
process of leukocyte activation, this b2 integrin is distributed
diffusely over the entire cellular membrane. As outlined above, we
show here that upon binding of CyaA the integrin relocates into
lipid rafts, due to toxin-induced and calcium-activated cleavage of
talin by calpain. Moreover, the recently discovered capacity of
CyaA to bind N-linked oligosaccharides of CD11b/CD18 [24]
might also play a role in this process. It is, indeed, plausible to
propose that CyaA interaction with terminal sialic acid residues of
glycan chains of raft sphingolipids might also be contributing to
accumulation of the CyaA-CD11b/CD18 complex in lipid rafts,
as well as it may contribute to clustering of lipid rafts containing
CyaA later-on. An evidence for CyaA interactions with ganglio-
sides can, indeed, be deduced from the previously observed
inhibition of CyaA activity on macrophages by the presence of
micromolar concentrations of free gangliosides, such as GT1b [23].
It remains to be addressed in future studies if CyaA can form
oligomeric pores also once engaged in interaction with the target
cell membrane through binding of the CD11b/CD18 receptor and
whether CyaA can form pore-forming oligomers also in phagocyte
membrane. We have recently succeeded in demonstrating the
presence of the long-predicted CyaA oligomers within the
membrane of cells lacking the receptor CD11b/CD18, such as
erythrocytes [10]. Vojtova-Vodolanova with co-authors (2009),
indeed, showed that formation of CyaA oligomers underlies the
pore-forming activity of CyaA towards erythrocytes. However,
despite significantly higher amounts of CyaA binding per single
phagocyte cell through the CD11b/CD18 receptor, fairly high
concentrations (.1 mg/ml) of the recombinant enzymatically
inactive but fully pore-forming CyaA-AC
2 variants are needed to
provoke lysis of cells like J774A.1 monocytes in several hours [8].
While this resistance to colloid-osmotic lysis is likely to be to large
extent due to membrane recycling mechanisms and pore removal
form phagocyte cytoplasmic membrane, it remainsto be shown that
CyaA can form oligomeric pores in leukocyte membrane as well.
The results presented here do not indicate any role of CyaA
oligomers in promoting calcium influx, toxin mobilization into
rafts, or AC enzyme translocation into CD11b
+ phagocytes. Early
dose-dependence studies indicated that the AC domain was
delivered across target cell membrane by CyaA monomers.
Indeed, toxin molecules with the AC domain cleaved-off by
cytosolic proteases, upon AC translocation into cells, were
detected exclusively in form of CyaA monomers within erythro-
cyte membranes and were excluded from the detected CyaA
oligomers [10]. Moreover, we used here the CyaA-
E570Q+K860R-AC
2 protein, which essentially lacks any pore-
forming activity and fails to permeabilize the membrane of
J774A.1 cells, thus being unlikely to form any CyaA oligomers
Table 2. Cholesterol content in J774 and U937 cells.
cells ng of cholesterol per 10
6 cells
untreated extracted
J774A.1 290635 140643
U937 - normal serum 89612 4768
U937 - delipidated serum 863 N.D.
Cholesterol was extracted from cells using 10 mM MbCD at 37uC for 30 min. U937
cells deficient in endogenous cholesterol synthesis were grown in RPMI medium
supplemented with 10% normal fetal calf serum or with 10% lipoprotein-deficient
serum from fetal calf (delipidated serum) for 48 h. Cholesterol content was deter-
mined using the Amplex Red Cholesterol Assay Kit (Molecular Probes). Values re-
present the mean 6 S.D. obtained from three independent experiments. N.D., not
detectable.
doi:10.1371/journal.ppat.1000901.t002
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buffer or treated with 10 mM MbCD at 37uC for 30 min, before CyaA was added for additional 10 min. CyaA binding and AC domain translocation
were determined as described in the legend to Fig. 3. Values represent the mean 6 S.D. from four independent experiments performed in triplicates.
An asterisk indicates a statistically significant difference (*, p,0.01; Student’s t test). (B) J774A.1 cells were kept in buffer or pretreated with 10 mM
MbCD at 37uC for 30 min and incubated with 1 nM CyaA for 10 min. Cell lyzates were analyzed as in Fig. 1A. (C) J774A.1 cells were loaded with the
Ca
2+ probe Fura-2/AM prior to cholesterol extraction with 10 mM MbCD at 30uC for 30 min. CyaA-mediated Ca
2+ influx was recorded as above.
Standard deviations were calculated for mean values at indicated time points and the shown curves are representative of at least three independent
experiments. (D) J774A.1 cells grown on coverslips were kept in buffer or pretreated with 10 mM MbCD at 37uC for 30 min. Membrane distribution of
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capable to translocate the AC domain into cytosol of CD11b-
expressing J774A.1 cells, to promote calcium influx and to
associate with DRM, or to co-localize with CtxB in coalesced
rafts, respectively (cf. Fig. 2). It appears, therefore, unlikely that
oligomerization plays a role in DRM association of CyaA.
We also observed here that the levels of binding of CyaA to
CD11b-expressing cells were not affected upon cholesterol
depletion of cell membrane, while the translocation of the AC
domain across the membrane depended strongly on the cholesterol
content. This suggests that by modulating the physical properties
lipid bilayers, cholesterol was specifically supporting the transloca-
tion of the AC domain across cell membrane. Indeed, cholesterol
removal was previously found to impair the residual penetration
capacity of CyaA on artificial membranes and erythrocytes [52,53].
This goes well with the impact of cholesterol concentration on
membrane fluidity, lateral phase separation, formation of liquid-
ordered structures and the propensity of lipids to adopt the inverted
hexagonal phase [54,55]. The same membrane properties would
also be expected to support AC domain translocation into cells by
lowering the energy barrier for polypeptide penetration into and
across the lipid bilayer [56]. It is plausible to speculate that
membrane translocation of the AC domain requires the presence of
cholesterol-dependent liquid-ordered (lo) phase, in which the acyl
chains of lipids are tightly packed, while the individual lipid
molecules have a high degree of lateral mobility. The relative
mobility of lipids in lo domains represents, indeed, a likely
prerequisite for passage of the AC domain across lipid bilayer. A
high condensation and immobility of lipids in liquid-disordered (ld)-
phase domains would, in turn, be expected to interfere with AC
polypeptide translocation. The requirement for sufficient mem-
brane fluidity for AC translocation to occur is also indicated by the
block of AC translocation at 4uC [38].
Recently, we demonstrated that AC domain translocation across
target cell membrane is accompanied by entry of Ca
2+ ions into
cells. Moreover, the AC domain polypeptide as such was found to
participate in formation of the transiently opened calcium influx
path in cell membrane [18]. Here, we used the 3D1 MAb
recognizing a distal segment of the AC domain and show that
blocking of AC domaintranslocationacrosscell membranecanlock
fluorescently labeled CyaA-AC
2 (6 nM, green) and CtxB (5 mg/ml, red) was visualized as described in the legend to Fig. 2. (E) U937 cells were grown
for 48 hours in RPMI medium supplemented with 10% fetal calf serum (standard serum) or with 10% lipoprotein-deficient serum from fetal calf
(delipidated serum). CyaA binding and AC domain translocation were determined as described in the legend to Fig. 3. Values represent the mean 6
S.D. from four independent experiments performed in triplicates. An asterisk indicates a statistically significant difference (*, p,0.01; Student’s t test).
(F) U937 cells grown in standard or delipidated serum were incubated with 1 nM CyaA at 37uC for 10 min, cell lyzates were separated on sucrose
density gradients and analyzed as in Fig. 1. (G) U937 cells grown in standard or delipidated serum were loaded with the Ca
2+ probe Fura-2/AM (3 mM)
at 25uC for 30 min, exposed to CyaA (17 nM) and the time course of Ca
2+ entry was recorded as above. Standard deviations were calculated for mean
values at indicated time points and the shown curves are representative of at least three independent experiments. (H) U937 cells cultured with
standard or delipidated serum were mounted on polylysin-coated coverslips and membrane distribution of fluorescently labeled CyaA-AC
2 (6 nM,
green) and CtxB (5 mg/ml, red) was visualized as described above.
doi:10.1371/journal.ppat.1000901.g006
Figure 7. AC domain of CyaA translocates across cellular membrane from lipid rafts. (A) J774A.1 cells were incubated at 37uC for 10 min
with 1 nM individual CyaA proteins (upper panel) or with their 1:1 mixtures (lower panel). CyaA and biotinylated CyaA-E570K+E581P (CyaA-
E570K+E581P-biotin) were detected in gradient fractions using 9D4 and streptavidine, respectively. (B) J774A.1 cells were incubated at 37uC for
10 min with the indicated pairs of proteins (12 nM) mixed in a 1:1 molar ratio. Binding of CyaA-E570K+E581P-biotin was determined as the amount of
total cell-associated AC enzyme activity upon exposure of cells to the protein mixtures and expressed as relative value. Enhancement of the residual
capacity of CyaA-E570K+E581P to translocate AC domain into J774A.1 cell cytosol (1.860.5% of intact CyaA activity) was measured by determination
of intracellular cAMP amounts accumulated in 10
6 cells upon exposure for 10 min at 37uC to the indicated 1:1 protein mixtures (12 nM). The values
represent the mean 6 S.D. from four independent experiments performed in duplicate. An asterisk indicates a statistically significant difference
(*, p,0.01; Student’s t test).
doi:10.1371/journal.ppat.1000901.g007
CyaA Translocation across Cell Membrane
PLoS Pathogens | www.plospathogens.org 11 May 2010 | Volume 6 | Issue 5 | e1000901CyaA in a ‘translocation intermediate’ conformation that forms a
pathforCa
2+influxacrosscell membrane(cf. Fig.3).Moreover,this
‘translocationintermediate’ was found to be recruited into lipid rafts
(Fig. 3). The sum of the data hence allows us to answer the question
what happens first, whether calcium influx precedes toxin
mobilization into rafts, or whether recruitment of CyaA into rafts
precedes calcium influx and AC translocation.
We showed here that calpeptin-mediated inhibition of calcium-
activated processing of talin by calpain yields (i) inhibition of CyaA
recruitment into rafts and (ii) it inhibits AC translocation across
membrane. Collectively, hence, these results strongly suggest that
the transientinfluxof Ca
2+ into cellsaccompanies the earliest step of
membrane insertion of the toxin ‘translocation intermediate’. This
would precede and be essential for subsequent recruitment of CyaA
into lipid rafts, whereupon AC translocation is accomplished.
It remains, however, to be determined what is the threshold of
the calcium signal required for initiation of talin cleavage and
mobilization of CyaA into lipid rafts. Two major isoforms of
calpain have, indeed, been so far identified in eukaryotic cells. The
calpain I (m-calpain) is activated at mMC a
2+ concentrations, while
calpain II (m-calpain) only responds to mM concentrations of Ca
2+
[57]. Here we observed that CyaA relocalization into DRM
occurred at 1 nM toxin concentration, which is about two-times
less than the lowest CyaA concentrations still allowing to elicit a
[Ca
2+]i increase detectable in cells by the Fura-2/AM probe [18].
Moreover, only influx of extracellular Ca
2+ ions into cells, and not
the elevation of cytosolic [Ca
2+]i due to Ca
2+ release from
intracellular stores, enabled the accumulation of CyaA in DRM
(cf. Fig. 4). This differs importantly from the mechanism reported
for localization of the leukotoxin (LtxA) of Actinobacillus actinomy-
cetemcomitans into rafts. LtxA binds yet another b2 integrin of
human leukocytes, the LFA-1 or CD11a/CD18 heterodimer.
Horeover, LtxA appears to first adsorb on cell membrane of T
lymphocytes in a receptor-independent manner, to trigger,
somehow the store-operated elevation of cytosolic [Ca
2+]i,t o
induce talin cleavage, and upon relocation into rafts, the Ltx
clusters with LFA-1 within rafts to promote cell lysis [58].
With CyaA, all the Ca
2+ ions entering macrophage cytoplasm
due to toxin action appear to come from extracellular medium
[18]. It is generally accepted that there exists a gradient of about
four orders of magnitude in Ca
2+ concentrations between the
external medium (,2 mM) and cell cytosol (,100 nM). There-
fore, numerous Ca
2+-buffering proteins accumulate beneath the
inner face of cell membrane, accounting for formation of local
Ca
2+ gradients and controlling signaling induced by alterations of
Ca
2+ concentrations in the submembrane compartment. These
concentrations can, indeed, be still much higher, and rise more
rapidly, than the bulk Ca
2+ levels in cell cytosol [59]. Therefore, it
is likely that even an importantly lower CyaA concentration than
used here (1 nM=176 ng/ml), may still be generating sufficiently
high local Ca
2+ signal beneath cell membrane in order to promote
activation of m-calpain at the inner face of cell membrane. It
appears, thus, plausible to assume that mobilization of CyaA into
rafts in phagocyte membrane, and translocation of the AC domain
from rafts directly into the cytosolic compartment of phagocytes,
are indeed taking place also during natural Bordetella infections in
vivo. This would account for the remarkable efficacy of CyaA in
disarming the sentinel cells of the host innate defense.
Materials and Methods
Expression and purification of CyaA-derived proteins
Intact recombinant CyaA and its mutant variants were
expressed and purified as previously described [19]. Except of
pro-CyaA, the CyaA proteins were produced in E. coli XL1-Blue
in the presence of the co-expressed toxin-activating acyltransferase
Figure 8. Model of CyaA translocation across target cell membrane. In the first step, CyaA binds the CD11b/CD18 integrin receptor
dispersed in the bulk of the membrane phase outside of lipid rafts, having the cytoplasmic tail of the CD18 subunit tethered to actin cytoskeleton via
the linker protein talin. Upon receptor engagement, a ‘translocation intermediate’ of CyaA inserts into the lipid bilayer of cell membrane with the AC
domain partially penetrating into cell membrane together with the pore-forming segments of the toxin and participating in formation of a transiently
opened Ca
2+-conducting path across cell membrane. Influx of external calcium ions into cells induces activation of the Ca
2+-dependent protease
calpain, yielding talin cleavage and liberation of the CyaA-CD11b/CD18 complex from binding to actin cytoskeleton. Consequently, CyaA is recruited
with CD11b/CD18 into cholesterol-enriched lipid rafts, where the liquid-ordered packing of lipids and the specific presence of cholesterol enable
completion of AC domain translocation across cytoplasmic membrane. Upon exposure at the cytosolic side of cell membrane, the AC domain is
cleaved-off from the RTX cytolysin moiety of CyaA by a protease residing inside the cell. Binding of cytosolic calmodulin (CaM) then activates the AC
enzyme and unregulated conversion of ATP to cAMP is catalyzed.
doi:10.1371/journal.ppat.1000901.g008
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eliminated by repeated 60% isoporopanol washes of CyaA bound
to the Phenyl Sepharose resin [60]. This reduced the final
endotoxin content below 50 EU/mg of purified protein, as
determined by the Limulus amebocyte lyzate assay (QCL-1000,
Cambrex, NJ, USA). For fluorescence microscopy, the CyaA
proteins were labeled while bound to Phenyl-Sepharose resin
during the final purification step. Briefly, the CyaA eluates from a
DEAE-Sepharose columns (GE Healthcare) in 50 mM Tris-HCl
(pH 8), 8 M urea, 0.2 mM CaCl2, 200 mM NaCl, were diluted
1:4 with a buffer containing 50 mM Tris-HCl (pH 8), 1 M NaCl
and 1 mg of CyaA was loaded on an 0.5 ml Phenyl-Sepharose
column. The columns were extensively washed with 0.1 M sodium
bicarbonate (pH 9), 1 M NaCl. Next 10 mg/ml Alexa Fluor 488
succinimidylester solution (Molecular Probes) was loaded and
labeling proceeded at 25uC for 1 hour. The columns were washed
with 50 mM Tris-HCl (pH 8), 1 M NaCl, and the CyaA-Alexa
Fluor 488 conjugates were eluted in a buffer containing 50 mM
Tris-HCl (pH 8), 8 M urea and 2 mM EDTA. Unreacted dye was
separated from labeled CyaA on Sephadex G-25 columns (GE
Healthcare). Efficiency of protein labeling was assessed spectro-
photometrically and a molar ratio of about 1:4 (protein:dye) was
found for all CyaA preparations. It was verified that this extent of
labeling did not affect the biological activities of CyaA.
Antibodies, reagents, cell lines, SDS-PAGE, BN-PAGE and
Western blotting
See Protocol S1 for full description.
Isolation of detergent-resistant membranes
Detergent-resistant membranes (DRM) were separated by
flotation in discontinuous sucrose density gradients. Briefly,
J774A.1 cells (2.10
7) were washed with prewarmed DMEM and
incubated with 1 nM CyaA proteins at 37uC for 10 min. Cells
were washed with ice-cold phosphate-buffered saline (PBS),
scraped from the Petri dish and extracted at 4uC for 60 min
using 200 ml of TBS buffer (20 mM Tris-HCl, pH 7.5, 150 mM
NaCl) containing 1% Triton X-100, 1 mM EDTA, 10 mM NaF
and a Complete Mini proteinase inhibitor cocktail (Roche, Basel,
Switzerland). The lyzates were clarified by centrifugation at 2506g
for 5 min and the post-nuclear supernatants were mixed with
equal volumes of 90% sucrose in TBS. The suspensions were
placed at the bottom of centrifuge tubes and overlaid with 2.5 ml
of 30% sucrose and 1.5 ml of 5% sucrose in TBS. Membrane
flotation according buoyant density was achieved by centrifugation
at 150,0006g in a Beckman SW60Ti rotor for 16 h at 4uC.
Fractions of 0.5 ml were removed from the top of the gradient.
Ca
2+ influx into cells
Calcium influx into J774A.1 and U937 cells was measured as
previously described [18]. Briefly, cells were loaded with 3 mM
Fura-2/AM (Molecular Probes) at 25uC for 30 min and the time
course of calcium entry into cells induced by addition 3 mg/ml of
CyaA proteins was determined as ratio of fluorescence intensities
(excitation at 340/380 nm, emmision 505 nm), using a Fluor-
oMax-3 spectrofluorometer equipped with DataMax software
(Jobin Yvon Horriba, France).
Depletion of cholesterol
J774A.1 cells were incubated in DMEM supplemented with
10 mM methyl-b-cyclodextrin (MbCD) at 37uC for 30 min.
Cholesterol-depleted U937 cells were obtained upon growth in
RPMI medium supplemented with 10% of delipidated serum
(lipoprotein-deficient serum from fetal calf, Sigma) for 48 h.
Cholesterol content was determined using an Amplex Red
Cholesterol Assay Kit (Molecular Probes, Invitrogen) according
to manufacturer’s instructions. Viability of cells was tested by
trypan blue staining and no significant cell death occurred upon
cholesterol extraction.
Fluorescence microscopy
U937 cells were grown in media with 10% standard, or
delipidated serum, and were mounted on polylysin-coated
coverslips prior to incubation with labeled proteins. J774.A1 cells
(5.10
4) were grown directly on coverslips ( w12 mm) and incubated
with Alexa Fluor 488-labeled CyaA proteins (6 nM) at 37uC for
10 min, before cells were washed and 5 mg/ml of Alexa Fluor 594-
labeled cholera toxin subunit B (CtxB) was added for additional
5 min. The unbound proteins were washed-off with ice-cold PBS,
cells were fixed with 4% paraformaldehyde in PBS at 25uC for
20 min, and mounted in Mowiol solution (Sigma). Fluorescence
images were taken using a Cell
R Imaging Station (Olympus,
Hamburg, Germany) based on Olympus IX 81 fluorescence
microscope, using a 1006 oil immersion objective (N.A. 1.3).
Digital images were processed using ImageJ software.
Immunoprecipitation
J774.A1 cells (10
6) were incubated with 17 nM CyaA in
DMEM for 30 min at 37uC, washed with Hank’s Buffered Salt
Solution buffer (HBSS), and lyzed at 4uC during 30 min in 500 ml
of Tris-buffered saline (pH 7.4) supplemented with 1% Triton X-
100 and EDTA-free Complete Mini proteinase inhibitor cocktail
(Roche, Basel, Switzerland). The lyzate was centrifuged for 15 min
at 10,0006g at 4uC, and the supernatant was incubated with
MEM-174 MAb covalently linked to CNBr-activated Sepharose
beads (GE Healthcare) at 4uC for 1 h. The beads were washed five
times with 1 ml of the lysis buffer and the bound proteins were
eluted with SDS-PAGE loading buffer and analyzed by SDS-
PAGE followed by Western blotting.
CyaA binding to cells
J774A.1 or U937 cells (10
6) were incubated with 6 nM CyaA
proteins at 37uC for 10 min, washed repeatedly in buffer, and the
amount of cell-associated adenylate cyclase (AC) activity was
determined in cell lyzates as previously described by [61].
cAMP assay
J774A.1 or U937 cells (10
6) were incubated with CyaA proteins
at indicated concentrations for 10 min at 37uC and intracelular
cAMP concentrations were determined in cell lyzates using a
competitive ELISA as previously described [62].
Supporting Information
Figure S1 Cholesterol depletion does not affect the tight binding
of CyaA to CD11b/CD18. J774A.1 (10
5) cells were pretreated
with 10 mM MbCD at 37uC for 30 min and placed on ice before
CyaA or pro-CyaA were added at indicated concentrations.
Proteins were allowed to bind CD11b/CD18 for 30 min at 4uC,
before 30 nM biotinylated CyaA was added for another 30 min on
ice. Cells were washed, stained with phycoerythrin-streptavidin
conjugate and amounts of bound biotinylated CyaA were
determined by flow cytometry. Results are expressed as relative
binding of biotinylated CyaA according to the formula=(sample
binding)/(maximum binding)6100. Data shown are the mean 6
S.D. from three independent experiments performed in duplicates.
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